The global “Nasal Drug Delivery Devices Market Size” is prognosticated to reach USD 81.85 billion by 2026 attributable to the increasing number of the patient population and the rising prevalence of ...

Using tap water for neti pots and other nasal-rinsing devices was linked to a potentially dangerous amoeba in a new study published by researchers from the U.S. Centers for Disease Control and ...

DUBLIN, Dec. 9, 2019 /PRNewswire/ -- The "Global Nasal High Flow Market - Analysis By Type (Consumables, Devices), Addressable Market (Hospitals, Homecare): Opportunities and Forecast (2019-2024)" ...

Cardamyst is now FDA approved as a self-administered intranasal treatment for acute episodes of paroxysmal supraventricular tachycardia.

University Medical Devices (UMD) closed a $1.6M round of seed funding led by Bright Minds Capital Partners, with participation from Invest Nebraska, AV Legacy Holdings, LLC and UMD executives. The ...

Replacing a complicated surgery with a minimally invasive approach is a tried and true formula in medtech. Menlo Park, California-based startup Spirox is aiming to do that with its device to treat ...

Spirox roped in $18.5 million in a Series B round to support development of its nasal obstruction device, giving the company a boost as it eyes U.S. regulatory approval for its product. Venrock and ...

If you have chronic nasal congestion, it could be due to an obstruction caused by the shape of your internal nasal valve. A new device is designed to permanently address the problem, without the need ...

Federal health officials have linked neti pots and other nasal-rinsing devices to another potentially dangerous amoeba. The Centers for Disease Control and Prevention (CDC) on Wednesday published a ...